BB Biotech’s Radius Health, Inc. RDUS Stock Holding History

BB Biotech’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$135M	Buy	6,781,685 +71,409	+1%	+$1.3M	3.4%	11
2018 Q4	$111M	Buy	6,710,276 +120,000	+2%	+$2.02M	3.54%	12
2018 Q3	$117M	Buy	6,590,276 +389,363	+6%	+$8.81M	3.1%	13
2018 Q2	$183M	Buy	6,200,913 +347,114	+6%	+$11M	5.28%	7
2018 Q1	$210M	Buy	5,853,799 +155,000	+3%	+$5.6M	5.81%	6
2017 Q4	$181M	Buy	5,698,799 +200,000	+4%	+$6.28M	5.1%	7
2017 Q3	$212M	Buy	5,498,799 +460,000	+9%	+$18.1M	5.87%	7
2017 Q2	$228M	Buy	5,038,799 +498,400	+11%	+$19M	6.97%	4
2017 Q1	$175M	Buy	4,540,399 +180,000	+4%	+$7.55M	5.74%	5
2016 Q4	$166M	Hold	4,360,399	–	–	6.14%	5
2016 Q3	$236M	Hold	4,360,399	–	–	8.29%	4
2016 Q2	$160M	Hold	4,360,399	–	–	6.33%	5
2016 Q1	$137M	Buy	4,360,399 +88,259	+2%	+$3.05M	5.45%	6
2015 Q4	$263M	Hold	4,272,140	–	–	7.41%	5
2015 Q3	$296M	Buy	4,272,140 +350,000	+9%	+$24.3M	9.39%	3
2015 Q2	$266M	Buy	3,922,140 +200,000	+5%	+$9.32M	7.2%	5
2015 Q1	$153M	Buy	3,722,140 +970,000	+35%	+$43.6M	4.56%	8
2014 Q4	$107M	Buy	2,752,140 +7,100	+0.3%	+$168K	3.47%	9
2014 Q3	$57.6M	Hold	2,745,040	–	–	2.34%	15
2014 Q2	$35.7M	Buy	+2,745,040	New	+$25.3M	1.7%	16

Other funds holding RDUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BB Biotech's RDUS Position: Q1 2019 in Review

BB Biotech increased its Radius Health, Inc. (RDUS) stake by 1.1% in Q1 2019, buying an estimated $1.3M and bringing the position to 6,781,685 shares worth $135M. The position accounts for 3.4% of the portfolio, ranked #11.

BB Biotech first reported a position in RDUS in Q2 2014 and has held it in 20 quarters since. The position peaked at $296M in Q3 2015. 127 funds tracked by Wall St. Rank hold RDUS as of Q1 2019.

BB Biotech held 6,781,685 shares of Radius Health, Inc. worth $135M as of Q1 2019.
BB Biotech bought 71,409 Radius Health, Inc. shares in Q1 2019, an estimated $1.3M.
Radius Health, Inc. made up 3.4% of BB Biotech's portfolio in Q1 2019, its #11 holding.
BB Biotech first reported a position in Radius Health, Inc. in Q2 2014 and has held it in 20 quarters since.
BB Biotech's Radius Health, Inc. position peaked at $296M in Q3 2015.
127 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2019.

Based on BB Biotech's 13F filing for Q1 2019, filed 13 May 2019.